Drug Therapy in the Heart Transplant Recipient
Open Access
- 4 January 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 111 (1) , 113-117
- https://doi.org/10.1161/01.cir.0000151609.60618.3c
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitorsAmerican Heart Journal, 2004
- Simvastatin Initiated Early After Heart TransplantationCirculation, 2003
- Prophylaxis Strategies for Solid‐Organ TransplantationClinical Infectious Diseases, 2001
- Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506Transplant International, 1998
- Immunohistochemical analysis of platelet-derived growth factor and basic fibroblast growth factor in cardiac biopsy and autopsy specimens of heart transplant patientsThe American Journal of Cardiology, 1996
- Time Course of the Decline in Renal Function in Cyclosporine-Treated Heart Transplant RecipientsAmerican Journal of Nephrology, 1994
- PREVENTION OF Pneumocystis carinii PNEUMONIA IN CARDIAC TRANSPLANT RECIPIENTS BY TRIMETHOPRIM SULFAMETHOXAZOLETransplantation, 1993
- Pharmacokinetics of cyclosporine in hyperlipidaemic long-term survivors of heart transplantationEuropean Journal of Clinical Pharmacology, 1992
- Cardiac transplant hypertensionThe American Journal of Cardiology, 1990
- Increased Pulmonary Superinfections in Cardiac-Transplant Patients Undergoing Primary Cytomegalovirus InfectionNew England Journal of Medicine, 1978